Huet Olivier, Cherreau Christaine, Nicco Carole, Dupic Laurent, Conti Marc, Borderie Didier, Pene Frédéric, Vicaut Eric, Benhamou Dan, Mira Jean-Paul, Duranteau Jacques, Batteux Frédéric
Département d'anesthésie réanimation, Hôpital Bicêtre, Assistance Publique des Hopitaux de Paris, France.
Crit Care Med. 2008 Aug;36(8):2328-34. doi: 10.1097/CCM.0b013e3181800387.
Plasma from septic shock patients can induce production of reactive oxygen species (ROS) by human umbilical vein endothelial cells (HUVEC) in vitro. How endothelial cells defend themselves against ROS under increased oxidative stress has not yet been examined. This study investigates the antioxidant defenses of HUVEC exposed to plasma obtained from either septic shock patients or healthy volunteers.
Prospective, observational study.
Medical intensive care unit in a university hospital.
Twenty-five patients with septic shock and 10 healthy volunteers.
Blood samples were collected within the first 24 hrs of septic shock. In vitro HUVEC production of ROS was studied by spectrofluorimetry using 2',7'-dichlorodihydrofluorescein diacetate fluorescent dye. Reactive nitrogen species were also assessed. Intracellular reduced glutathione (GSH) levels were measured using monochlorobimane fluorescent dye. Activity of catalase and superoxide dismutase in HUVEC were also measured. Cell death was assessed using YOPRO fluorescent dye and the MTT assay.
On admission, the septic shock population's mean age was 55 yrs old, the mean Sequential Organ Failure Assessment score was 12, mean simplified acute physiology score was 50, and intensive care unit mortality rate was 45%. Evaluation of HUVEC antioxidant defenses showed a significantly decreased GSH level, increased catalase activity, and unchanged superoxide dismutase activity. ROS levels and cell death were significantly reduced when cells were pretreated with N-acetylcysteine or GSH, but no changes in reactive nitrogen species were observed.
This study demonstrates that plasma-induced ROS production by HUVEC is associated with an intracellular decrease in reduced GSH. Both ROS levels and cell death decreased when N-acetylcysteine or GSH were added before exposing the cells to plasma. These data suggest a pivotal role of alterations in GSH in damage caused by sepsis-generated ROS in endothelial cell.
脓毒性休克患者的血浆可在体外诱导人脐静脉内皮细胞(HUVEC)产生活性氧(ROS)。目前尚未研究内皮细胞在氧化应激增加的情况下如何抵御ROS。本研究调查了暴露于脓毒性休克患者或健康志愿者血浆中的HUVEC的抗氧化防御机制。
前瞻性观察性研究。
大学医院的医学重症监护病房。
25例脓毒性休克患者和10名健康志愿者。
在脓毒性休克的最初24小时内采集血样。使用2',7'-二氯二氢荧光素二乙酸荧光染料通过荧光分光光度法研究体外HUVEC产生ROS的情况。还评估了活性氮。使用单氯双胺荧光染料测量细胞内还原型谷胱甘肽(GSH)水平。还测量了HUVEC中过氧化氢酶和超氧化物歧化酶的活性。使用YOPRO荧光染料和MTT试验评估细胞死亡情况。
入院时,脓毒性休克患者群体的平均年龄为55岁,平均序贯器官衰竭评估评分是12分,平均简化急性生理学评分是50分,重症监护病房死亡率为45%。对HUVEC抗氧化防御机制的评估显示,GSH水平显著降低,过氧化氢酶活性增加,超氧化物歧化酶活性未改变。当细胞用N-乙酰半胱氨酸或GSH预处理时,ROS水平和细胞死亡显著降低,但活性氮未观察到变化。
本研究表明,HUVEC由血浆诱导产生ROS与细胞内还原型GSH减少有关。在将细胞暴露于血浆之前添加N-乙酰半胱氨酸或GSH时,ROS水平和细胞死亡均降低。这些数据表明,GSH改变在脓毒症产生的ROS对内皮细胞造成的损伤中起关键作用。